TED (EU)
Germany – Pharmaceutical products – Vereinbarung nach § 130c Abs. 1 SGB V für das Arzneimittel Epclusa mit der Wirkstoffkombination Sofosbuvir/Velpatasvir
Awarded
EU
29
Key details
Region
Germany
Sector
Contract value
Not stated by buyer
Submissions closed
Not stated by buyer
Published
27 July 2026
Procurement
Contract period
1 September 2026 - 31 August 2028
2026-09-01 to 2028-08-31
Procedure type
neg-wo-call
CPV classifications
- 33600000 Pharmaceutical products
What happened
The buyer awarded this contract to Gilead Sciences GmbH on 14 Jul 2026. The contract runs until 31 Aug 2028.
Description
Vereinbarung gemäß § 130c Abs.1 SGB V für das Arzneimittel Epclusa mit der Wirkstoffkombination Sofosbuvir/Velpatasvir.
Awarded supplier
Supplier
Gilead Sciences GmbH
Award date
14 July 2026
Contact
Address
Augustinerstraße 38, Erfurt, 99084
Contact name
Geschäftsbereich Unternehmenssicherheit, Vergabestelle
Email
Phone
Explore related tenders
External ID: ted-520789-2026 • Added 28 July 2026